CDKN2B-AS1 and pancreatic neoplasm: Interestingly, contrary to its above results, miR-181a was significantly lower in both pancreatic cancer tissues and cell lines (Figure 1C), which indicate that miR-181a may be regulated by ANRIL, which promotes the expression of HMGB1.